title: Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. II. Degradation of isolated bovine nasal cartilage proteoglycan.
abstract: Extracts of human peripheral blood polymorphonuclear leukocyte granules, and two purified proteases derived from such extracts, an elastase and a chymotrypsin-like enzyme, degrade isolated bovine nasal cartilage proteoglycan at neutral pH. Viscosity studies indicate that the leukocyte granule extracts lack hyaluronidase activity and that their degradative effect on proteoglycan at physiological pH is due entirely to proteolytic action. Sepharose 4B gel chromatography and SDS-polyacrylamide gel electrophoresis of proteoglycan fractions treated with leukocyte granule enzymes at pH 7.0 indicate that they degrade one of the proteoglycan link proteins, release a fragment from the hyaluronic acid-binding portion of the proteoglycan subunit core protein, and break down the remainder of the proteoglycan subunit molecule into peptide fragments with varying numbers of chondroitin sulfate chains. Immunodiffusion studies indicate that the antigenic determinants of the proteoglycan subunit core protein and the link proteins survive treatment with granule proteases. Similar degradation of human articular cartilage proteoglycan by granule neutral proteases can be presumed to occur, in view of the similarity of structure of human articular and bovine nasal cartilage proteoglycans. The release of granule enzymes in the course of neutrophil-mediated inflammation can thus result in the degradation of cartilage matrix proteoglycan, leading to cartilage destruction and joint injury.
mesh_terms: D000818:Animals; D001168:Arthritis / Q000209:etiology; D002358:Cartilage, Articular / Q000187:drug effects / Q000378:metabolism*; D002417:Cattle; D055598:Chemical Phenomena; D002621:Chemistry; D002809:Chondroitin Sulfates / Q000378:metabolism; D002850:Chromatography, Gel; D002918:Chymotrypsin / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000378:metabolism*; D004195:Disease Models, Animal; D004591:Electrophoresis, Polyacrylamide Gel; D006025:Glycosaminoglycans / Q000378:metabolism*; D006801:Humans; D005779:Immunodiffusion; D007592:Joint Diseases / Q000378:metabolism*; D007962:Leukocytes / Q000648:ultrastructure*; D009300:Nasal Septum; D010196:Pancreatic Elastase / Q000494:pharmacology; D011509:Proteoglycans / Q000032:analysis / Q000378:metabolism*; D012967:Sodium Dodecyl Sulfate; D014783:Viscosity
chemical_list: D006025:Glycosaminoglycans; D011509:Proteoglycans; D012967:Sodium Dodecyl Sulfate; D002809:Chondroitin Sulfates; D002918:Chymotrypsin; D010196:Pancreatic Elastase